| |
 You have a chemical library and you want to evaluate the therapeutic potential of your molecules in the CNS
Neuréva has developed original in vitro & in vivo preclinical models of CNS diseases.
Our wide catalogue of analyzing techniques includes classic approaches and sophisticated real-time follow up tools (NMR, automated analysis of locomotion).
|
|
You
have identified neuroprotective molecules in your pipeline and you want
to determine the therapeutic window and evaluate the effects of the
treatment in real time.
Neuréva develops innovative technologies
leading to time & space in vivo monitoring of: (1) the progression
of the pathology; (2) the therapeutic response to neuroprotective
treatments and to (3) the precise determination of therapeutic windows.
|
|
 |
 |
MEMORIES |
European Union grants the MEMORIES specific targeted research. Neureva as a part of the European consortium is involved in this three years project. Read more
|
 |
RESCUE |
From stem cell technology to functional restoration after spinal cord injury (RESCUE). Read more
|
 [ more news ] |
| |
You need strong scientific expertise and know-how to develop new therapeutic hypotheses in the CNS domain.
During the last three decades we, as academics, have achieved acknowledged advances in the analytic and therapeutic approaches for the treatment of CNS diseases.
Our expertise on mice models of CNS pathologies
allows us to test molecular and cellular pathophysiological hypotheses
based on the wide library of knock-out and transgenic mice. |
|
You are an academic lab and you are looking for an industrial partnership for developing original therapeutic hypotheses.
Development
of original and innovative therapeutic solutions is a long and costly
process which requires reactivity, precision and efficiency.
We offer you a real partnership to promote an industrial value for your ideas. |
|
